Tcw Group Inc Amneal Pharmaceuticals, Inc. Transaction History

Tcw Group Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 07, 2019	SELL	$6.44 - $14.29 $14.8 Million - $32.9 Million	-2,302,363 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$11.87 - $14.84 $752,831 - $941,197	63,423 Added 2.83%	2,302,363 $32.6 Million
Q4 2018 Feb 11, 2019	SELL	$13.09 - $21.49 $3.69 Million - $6.06 Million	-282,124 Reduced 11.19%	2,238,940 $30.3 Million
Q3 2018 Oct 30, 2018	SELL	$16.4 - $24.27 $1.02 Million - $1.51 Million	-62,098 Reduced 2.4%	2,521,064 $55.9 Million
Q2 2018 Aug 02, 2018	BUY	$13.95 - $20.2 $36 Million - $52.2 Million	2,583,162 New	2,583,162 $42.4 Million

183

141M

234K

45.9K

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.37B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

Get notified when there are updates to the investment portfolio of Tcw Group Inc, based on Form 13F filings with the SEC.

Stay updated on Tcw Group Inc with notifications on news.